ZDA
TWST icon

Zweig-DiMenna Associates’s Twist Bioscience TWST Stock Holding History

Zweig-DiMenna Associates’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-7,528
Closed -$805K – 147
2021
Q3 		$805K Hold
7,528
– – 0.06% 148
2021
Q2 		$1M Buy
+7,528
New +$875K 0.06% 166

Other funds holding TWST

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Zweig-DiMenna Associates's TWST Position: Q4 2021 in Review

Zweig-DiMenna Associates sold out of Twist Bioscience (TWST) in Q4 2021, closing a stake of 7,528 shares — an estimated $805K sold.

Zweig-DiMenna Associates first reported a position in TWST in Q2 2021 and held it in 2 quarters. The position peaked at $1M in Q2 2021. 236 funds tracked by Wall St. Rank hold TWST as of Q4 2021.

  • Zweig-DiMenna Associates reported no remaining Twist Bioscience position as of Q4 2021 after selling out during the quarter.
  • Zweig-DiMenna Associates sold 7,528 Twist Bioscience shares in Q4 2021, an estimated $805K.
  • Zweig-DiMenna Associates first reported a position in Twist Bioscience in Q2 2021 and held it in 2 quarters.
  • Zweig-DiMenna Associates's Twist Bioscience position peaked at $1M in Q2 2021.
  • 236 funds tracked by Wall St. Rank held Twist Bioscience as of Q4 2021.

Based on Zweig-DiMenna Associates's 13F filing for Q4 2021, filed 27 Jan 2022.